| Table 1. Clinical data, hormonal profile and reproductive outcomes of infertile euthyroid women participating in this study. | |
| Characteristics* | Median [IQR] |
|---|---|
| ( |
|
| Female age (years) | 35 [32 - 38] |
| BMI (kg/cm2) | 22.96 [21.36 - 25.02] |
| Time trying to conceive (months) | 24 [12 - 42] |
| Baseline FSH (UI/mL) | 6.56 [5.30 - 7.73] |
| LH (mUI/mL) | 5.50 [4.00 - 7.11] |
| Estradiol (pg/dL) | 47.77 [33.00 - 71.37] |
| Prolactin (ng/mL) | 13.02 [9.20 - 17.83] |
| TSH (mUI/mL) | 1.76 [1.17 - 2.37] |
| FT4 (ng/dL) | 1.14 [1.00 - 1.26] |
| Thyroid Peroxidase Antibody positive
( |
58 (13.6%) |
| Oocytes retrieved
( |
9 [5 - 14] |
| MII oocytes ( |
7 [4 - 11] |
| Embryos ( |
4 [2 - 6] |
| Embryos transferred
( |
2 [1 - 2] |
| Clinical Pregnancy rate
( |
197 (46%) |
| Miscarriage ( |
23 (11.7%) |
| Live births ( |
174 (88.3%) |
| Twins ( |
44 (25.3%) |
| Preterm ( |
31 (17.8%) |
*Qualitative variables are presented as absolute and relative frequencies, and quantitative variables are presented as mean and standard deviation and/or median and interquartile range (IQR). BMI, Body Mass Index; FSH: Follicle-stimulating hormone; LH: Luteinizing hormone; TSH, thyroid-stimulating hormone; FT4, free Thyroxine MII: Metaphase II oocytes.